The massive plastic production worldwide leads to a global concern for the pollution made by the plastic wastes and the environmental issues associated with them. One of the best solutions is replacing the fossil-based plastics with bioplastics. Bioplastics such as polylactic acid (PLA) are biodegradable materials with less greenhouse gas (GHG) emissions. PLA is a biopolymer produced from natural resources with good mechanical and chemical properties, therefore, it is used widely in packaging, agriculture, and biomedical industries. PLA products mostly end up in landfills or composting. In this review paper, the existing life cycle assessments (LCA) for PLA were comprehensively reviewed and classified. According to the LCAs, the energy and materials used in the whole life cycle of PLA were reported. Finally, the GHG emissions of PLA in each stage of its life cycle, including feedstock acquisition and conversion, manufacturing of PLA products, the PLA applications, and the end of life (EoL) options, were described. The most energy-intensive stage in the life cycle of PLA is its conversion. By optimizing the conversion process of PLA, it is possible to make it a low-carbon material with less dependence on energy sources.

Poly(2-hydroxyethyl methacrylate) (pHEMA) as a biomaterial with excellent biocompatibility and cytocompatibility elicits a minimal immunological response from host tissue making it desirable for different biomedical applications. This article seeks to provide an in-depth overview of the properties and biomedical applications of pHEMA for bone tissue regeneration, wound healing, cancer therapy (stimuli and non-stimuli responsive systems), and ophthalmic applications (contact lenses and ocular drug delivery). As this polymer has been widely applied in ophthalmic applications, a specific consideration has been devoted to this field. Pure pHEMA does not possess antimicrobial properties and the site where the biomedical device is employed may be susceptible to microbial infections. Therefore, antimicrobial strategies such as the use of silver nanoparticles, antibiotics, and antimicrobial agents can be utilized to protect against infections. Therefore, the antimicrobial strategies besides the drug delivery applications of pHEMA were covered. With continuous research and advancement in science and technology, the outlook of pHEMA is promising as it will most certainly be utilized in more biomedical applications in the near future. The aim of this review was to bring together state-of-the-art research on pHEMA and their applications.